Systems biology-based diagnostic principles as pillars of the bridge between Chinese and Western medicine.
暂无分享,去创建一个
Thomas Hankemeier | Jan van der Greef | Guowang Xu | T. Hankemeier | Guowang Xu | J. van der Greef | H. V. van Wietmarschen | Mei Wang | Jan Schroën | Mei Wang | Herman van Wietmarschen | Jan Schroën
[1] Sonali Patil,et al. Getting Started in Biological Pathway Construction and Analysis , 2008, PLoS Comput. Biol..
[2] Satoru Kawai,et al. An Algorithm for Drawing General Undirected Graphs , 1989, Inf. Process. Lett..
[3] J. Smolen,et al. Challenges of predicting treatment response in patients with rheumatoid arthritis , 2005, Nature Clinical Practice Rheumatology.
[4] G. Lewith,et al. Circular instead of hierarchical: methodological principles for the evaluation of complex interventions , 2006 .
[5] Barker Bausell,et al. Variability in the traditional Chinese medicine (TCM) diagnoses and herbal prescriptions provided by three TCM practitioners for 40 patients with rheumatoid arthritis. , 2005, Journal of alternative and complementary medicine.
[6] T. Huizinga,et al. Emerging patterns of risk factor make-up enable subclassification of rheumatoid arthritis. , 2007, Arthritis and rheumatism.
[7] I. Kirsch,et al. Listening to Prozac but Hearing Placebo: A Meta-Analysis of Antidepressant Medication , 1998 .
[8] R. Straub,et al. Neuroendocrine immune pathways in chronic arthritis. , 2008, Best practice & research. Clinical rheumatology.
[9] F. Benedetti,et al. Electrophysiological properties of thalamic, subthalamic and nigral neurons during the anti‐parkinsonian placebo response , 2009, The Journal of physiology.
[10] Fabrizio Benedetti,et al. New Insights into the Placebo and Nocebo Responses , 2008, Neuron.
[11] J. Lovelock,et al. Atmospheric homeostasis by and for the biosphere: the gaia hypothesis , 1974 .
[12] W. Jonas,et al. Placebo research: the evidence base for harnessing self-healing capacities. , 2004, Journal of alternative and complementary medicine.
[13] Cheng Lu,et al. Correlations Between Symptoms as Assessed in Traditional Chinese Medicine (TCM) and ACR20 Efficacy Response: A Comparison Study in 396 Patients With Rheumatoid Arthritis Treated With TCM or Western Medicine , 2007, Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases.
[14] D. Symmons. Epidemiology of rheumatoid arthritis: determinants of onset, persistence and outcome. , 2002, Best practice & research. Clinical rheumatology.
[15] Thomas Hankemeier,et al. Effects of growth conditions and processing on Rehmannia glutinosa using fingerprint strategy. , 2006, Planta medica.
[16] Bengt Lindström,et al. Salutogenesis , 2005, Journal of Epidemiology and Community Health.
[17] Claudia Mauri,et al. Cells of the synovium in rheumatoid arthritis , 2007 .
[18] Jan van der Greef,et al. Quality and safety of Chinese herbal medicines guided by a systems biology perspective. , 2009, Journal of ethnopharmacology.
[19] C. Otto Scharmer,et al. Theory U: Leading from the Future as it Emerges , 2007 .
[20] K. Moudgil,et al. Celastrus aculeatus Merr. suppresses the induction and progression of autoimmune arthritis by modulating immune response to heat-shock protein 65 , 2007, Arthritis research & therapy.
[21] J J Anderson,et al. Factors predicting response to treatment in rheumatoid arthritis: the importance of disease duration. , 2000, Arthritis and rheumatism.
[22] D. Fox,et al. Cells of the synovium in rheumatoid arthritis , 2007 .
[23] Harald Walach,et al. The therapeutic effect of clinical trials: understanding placebo response rates in clinical trials – A secondary analysis , 2005, BMC medical research methodology.
[24] Matej Oresic,et al. Integrative biological analysis of the APOE*3-leiden transgenic mouse. , 2004, Omics : a journal of integrative biology.
[25] G. Moddeman,et al. Unraveling the Mystery of Health , 1995 .
[26] Reinhard Guthke,et al. Rheumatoid arthritis, a complex multifactorial disease: On the way toward individualized medicine , 2006, Medicinal research reviews.
[27] A. Antonovsky. Unraveling the mystery of health: how people manage stress and stay well , 1987 .
[28] F. Benedetti. Mechanisms of placebo and placebo-related effects across diseases and treatments. , 2008 .
[29] K. Tracey,et al. Autonomic neural regulation of immunity , 2005, Journal of internal medicine.
[30] Sebastian Sauer,et al. Facets of mindfulness – Results of an online study investigating the Freiburg mindfulness inventory , 2009 .
[31] S. Banerjee,et al. Inhibition of type II collagen induced arthritis in mice by an immunosuppressive extract of Tripterygium wilfordii Hook f. , 1992, The Journal of rheumatology.
[32] J. van der Greef,et al. The role of analytical sciences in medical systems biology. , 2004, Current opinion in chemical biology.
[33] H. Tan,et al. The effect of Chinese herbal medicines (CHM) on menopausal symptoms compared to hormone replacement therapy (HRT) and placebo. , 2007, Maturitas.
[34] A. Gaines,et al. Physicians of Western Medicine , 1984 .
[35] Giovanni Maciocia,et al. The Foundations of Chinese Medicine: A Comprehensive Text for Acupuncturists and Herbalists , 2005 .
[36] W. Pagel. Prognosis and Diagnosis: A Comparison of Ancient and Modern Medicine , 1939, Journal of the Warburg Institute.
[37] Wayne B Jonas,et al. Deconstructing the Placebo Effect and Finding the Meaning Response , 2002, Annals of Internal Medicine.
[38] Khalil M. Dirani. Theory U: Leading from the Future as it Emerges , 2011 .
[39] Blair T. Johnson,et al. Initial Severity and Antidepressant Benefits: A Meta-Analysis of Data Submitted to the Food and Drug Administration , 2008, PLoS medicine.
[40] S. L. Bridges. Personalized medicine in rheumatoid arthritis: hopes and challenges. , 2007, Bulletin of the NYU hospital for joint diseases.
[41] P. Lipsky,et al. Benefit of an extract of Tripterygium Wilfordii Hook F in patients with rheumatoid arthritis: a double-blind, placebo-controlled study. , 2002, Arthritis and rheumatism.
[42] Guowang Xu,et al. Systems Biology Guided by Chinese Medicine Reveals New Markers for Sub-Typing Rheumatoid Arthritis Patients , 2009, Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases.
[43] F. Breedveld,et al. Antibodies to citrullinated proteins and differences in clinical progression of rheumatoid arthritis , 2005, Arthritis research & therapy.
[44] N. Kohls,et al. Spirituality, Suffering, and the Self , 2010 .
[45] C. Lam,et al. Safety and efficacy of Ganoderma lucidum (lingzhi) and San Miao San supplementation in patients with rheumatoid arthritis: a double-blind, randomized, placebo-controlled pilot trial. , 2007, Arthritis and rheumatism.
[46] C. Wijbrandts,et al. Rheumatoid arthritis subtypes identified by genomic profiling of peripheral blood cells: assignment of a type I interferon signature in a subpopulation of patients , 2007, Annals of the rheumatic diseases.
[47] R. Callard,et al. Cytokines, chaos, and complexity. , 1999, Immunity.
[48] J. Gaston,et al. Cytokines in arthritis--the 'big numbers' move centre stage. , 2008, Rheumatology.
[49] M. Liang,et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. , 1988, Arthritis and rheumatism.
[50] K. Wilber. The Marriage of Sense and Soul: Integrating Science and Religion , 1998 .
[51] T. Hankemeier,et al. Metabolomics-based systems biology and personalized medicine: moving towards n = 1 clinical trials? , 2006, Pharmacogenomics.
[52] Bridges Sl. Personalized medicine in rheumatoid arthritis: hopes and challenges. , 2007 .
[53] G. Lewith,et al. The Impact of Positive and Negative Spiritual Experiences on Distress and the Moderating Role of Mindfulness , 2009 .
[54] J. van der Greef,et al. The art and practice of systems biology in medicine: mapping patterns of relationships. , 2007, Journal of proteome research.
[55] P. V. van Riel,et al. Is the disease course of rheumatoid arthritis becoming milder? Time trends since 1985 in an inception cohort of early rheumatoid arthritis. , 2005, Arthritis and rheumatism.
[56] F. Capra. The hidden connections : integrating the biological, cognitive, and social dimensions of life into a science of sustainability , 2002 .
[57] Xuegong Zhang,et al. Understanding ZHENG in traditional Chinese medicine in the context of neuro-endocrine-immune network. , 2007, IET systems biology.
[58] David B Jackson. Clinical and economic impact of the nonresponder phenomenon--implications for systems based discovery. , 2009, Drug discovery today.
[59] Xin Chen,et al. Chemokines and chemokine receptors as novel therapeutic targets in rheumatoid arthritis (RA): inhibitory effects of traditional Chinese medicinal components. , 2004, Cellular & molecular immunology.
[60] J. van der Greef,et al. Systems biology, connectivity and the future of medicine. , 2005, Systems biology.
[61] A. Terzic,et al. The Merck Manual, 18th Edition , 2007, Clinical pharmacology and therapeutics.
[62] J. Greef,et al. Rescuing drug discovery: in vivo systems pathology and systems pharmacology , 2005, Nature Reviews Drug Discovery.
[63] Jan Schroën,et al. Non-linear dynamics and Chinese medicine: an essay on research models, TCM, and recent changes in modern scientific philosophy , 2002 .
[64] Wen-yue Jiang,et al. Therapeutic wisdom in traditional Chinese medicine: a perspective from modern science. , 2005, Trends in pharmacological sciences.
[65] Jeffrey Mervis. Science and the stimulus. Science and the stimulus. , 2009, Science.
[66] John P. Higgins,et al. Nonlinear systems in medicine. , 2002, The Yale journal of biology and medicine.
[67] R. Witkamp,et al. Metabolomics in the context of systems biology: bridging traditional Chinese medicine and molecular pharmacology , 2005, Phytotherapy research : PTR.
[68] L. Pearcy. Diagnosis as narrative in ancient literature. , 1992, American journal of philology.